Industries > Pharma > Pre-Filled Syringes Market Forecast 2016-2026
Pre-Filled Syringes Market Forecast 2016-2026
Prospects for Leading Companies in Plastic Pre-Filled Syringes, Pen Injector & Autoinjectors, and Glass Pre-Filled Syringes
What can be expected from the pre-filled syringes market? Which areas are going to grow at the fastest rates? This Visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects there.
Our 206-page report provides 123 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall regional market and national level. You will see financial results, an interview, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.
Forecasts from 2016-2026 and other analyses show you commercial prospects
Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT and STEP analysis) and commercial developments.
See revenue forecasts for the leading submarkets and indications
How will submarkets perform to 2026? Our study forecasts revenues in the following national submarkets:
• National and Regional Markets
• Leading Therapeutic Sectors
• Leading Pre-Filled Device Therapies
• Pre-Filled Syringe and Related Technology Manufacturers
Leading companies and potential for market growth
Overall revenue for the Pre-filled syringe market will reach $6,940m in 2020, our work forecasts. We predict strong revenue growth through to 2026. A number of new injectable drugs and advances in technology are seen as factors driving growth over the forecast period.
Our work analyses the key companies in the market. See Visiongain’s analysis of 14 leading companies, including these:
• Becton, Dickinson and Company
• Gerresheimer
• Schott
• Baxter
• Nipro
• Weigao
• Unilife
• Roselabs
• SHL Group
• Ypsomed
• Haselmeier
• Owen Mumford
• Bespak
• Datwyler
A company profile gives you the following information where available:
• Discussion of a company’s activities and outlook
• Company news relevant to the market
• Historical revenues
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
What issues will affect the Pre-Filled Syringe industry?
Our new report discusses issues and events affecting the pre-filled syringe market. You will find discussions, including qualitative analyses on a range of topics.
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Pre-Filled Syringes Market 2016-2026 report helps you
In summary, our 206-page report gives you the following knowledge:
• Revenue forecasts to 2026 for the Pre-Filled Syringes market – discover the industry’s prospects, finding promising places for investments and revenues
• Revenue forecasts to 2026 for the leading national markets – US, Japan, EU5, BRIC
• Revenue forecasts to 2026 for submarkets – discover prospects for leading therapeutic areas, as well as products within these areas. Identify the key trends driving and restraining growth in the market, including government policy and economic conditions relevant to the market.
• Assessment of 14 leading companies – historical revenue, news and upcoming product releases
• Discussion of what stimulates and restrains the market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the pre-filled syringes market and leading companies. You will find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1. Global Pre-Filled Syringes Market Overview
1.2. Global Pre-Filled Syringes Market Segmentation
1.3. Why You Should Read This Report
1.4. How This Report Delivers
1.5. Key Questions Answered by This Analytical Report
1.6. Who is This Report For?
1.7. Methodology
1.8. Frequently Asked Questions (FAQ)
1.9. Associated Visiongain Reports
1.10. About Visiongain
2. Introduction to Pre-Filled Syringes
2.1. What are Pre-Filled Syringes?
2.2. A Brief History of Pre-Filled Syringes
2.3. Design and Manufacture of Pre-Filled Syringes
2.3.1. Glass and Plastic Syringes
2.3.2. Safety and the Pre-Filled Syringe Market
2.3.3. Concerns over Needlestick Injuries
2.4. An Introduction to Pen Injectors and Autoinjectors
2.4.1. Pen Injectors and Autoinjectors Offer Advantages in Self-Administration
2.4.2. What Determines Injection Device Choice?
2.5. Glass versus Plastic
2.5.1. Glass
2.5.2. Plastic
2.6. Future Directions for Pre-Filled Syringes
2.7. Pre-Filled Syringes: Market Segmentation
2.8. Scope of this Report
2.8.1. Products Excluded from this Report
2.9. Currency Exchange Rates in This Report
3. Pre-Filled Syringes: World Market 2016-2026
3.1. Pre-Filled Syringes as a Share of the Global Drug Delivery Market
3.2. The World Pre-Filled Syringes Market in 2015
3.2.1. World Pre-Filled Syringes Market: Market Shares by Segment 2015
3.2.2. Leading Companies in the Pre-Filled Syringes Market
3.3. World Pre-Filled Syringes Market: Sales Forecast by Value, 2016-2026
3.4. How Will Segmental Market Shares Change to 2026?
3.5. World Pre-Filled Syringes Market: Drivers and Restraints 2016-2026
3.5.1. Biologics and Biosimilars to Drive Market Growth
3.5.2. Human Factors and Regulatory Requirements
3.5.3. Advances in Pre-Filled Syringe Manufacturing
3.5.4. Market Genericisation and Pre-Filled Syringes
3.5.5. The Injectable Drug Pipeline is Substantial
3.5.6. Competing Drug Delivery Technologies
3.6. Glass Pre-Filled Syringes Lead the Pre-Filled Syringes Market
3.6.1. Glass Pre-Filled Syringes Market: Sales Forecast by Value, 2016-2026
3.6.2. Glass Pre-Filled Syringes: Drivers and Restraints 2016-2026
3.7. Plastic Pre-Filled Syringes: Rapid Growth Forecasted
3.7.1. Plastic Pre-Filled Syringes Market: Sales Forecast by Revenue, 2016-2026
3.7.2. Plastic Pre-Filled Syringes: Drivers and Restraints 2016-2026
3.8. Pen Injectors and Autoinjectors: A Growing Segment
3.8.1. Pen Injectors and Autoinjectors Market: Sales Forecast by Value, 2016-2026
3.8.2. Pen Injectors and Autoinjectors: Drivers and Restraints 2016-2026
3.8.3. Insulin and Other Biologics to Lead Market Growth
4. Leading National and Regional Markets 2016-2026
4.1. National Breakdown of the World Pre-Filled Syringes Market
4.2. World Pre-Filled Syringes Market: National Markets Forecast 2016-2026
4.2.1. How Will National Market Shares Change to 2026?
4.3. Regional Breakdown of the World Pre-Filled Syringes Market
4.4. World Pre-Filled Syringes Market: Regional Markets Forecast 2016-2026
4.4.1. How Will Regional Market Shares Change to 2026?
4.5. US Pre-Filled Syringes Market Forecast 2016-2026
4.5.1. US Pre-Filled Syringes Market: Trends and Developments
4.5.1.1. New Drug and Device Launches to Drive Growth to 2026
4.5.1.2. The Budget Control Act 2011 and the Medical Excise Tax
4.6. Japanese Pre-Filled Syringes Market Forecast 2016-2026
4.7. EU5 Pre-Filled Syringes Market Forecast 2016-2026
4.8. Emerging Markets: Pre-Filled Syringes Market Forecast 2016-2026
4.8.1. Pre-Filled Syringe Manufacturers Are Investing in Emerging Markets
4.8.2. Chinese Pre-Filled Syringes Market Forecast 2016-2026
4.8.3. Indian Pre-Filled Syringes Market Forecast 2016-2026
4.8.4. Russian Pre-Filled Syringes Market Forecast 2016-2026
4.8.5. Brazilian Pre-Filled Syringes Market Forecast 2016-2026
5. Leading Therapeutic Sectors for Pre-Filled Syringes 2016-2026
5.1. Leading Therapeutic Sectors for Pre-Filled Syringes and Other Injection Devices in 2015
5.1.1. Vaccines and Heparins Are Major Market Sectors
5.1.2. Rising Demand in Chronic Conditions: Autoimmune Diseases and Diabetes
5.1.3. Growth for Key Market Sectors 2016-2026
5.2. Pre-Filled Syringes and Pen Injectors for Diabetes 2016-2026
5.2.1. Insulin Market Forecast 2016-2026
5.2.2. High Rates of Pen Injector Use in the EU and Japan
5.2.3. Insulin Pumps: A Technology to Challenge Pen Injectors to 2026?
5.2.4. MannKind’s Afrezza: Inhalable Insulin Approved in US
5.2.5. Injection Devices for Biosimilar Insulin Products
5.3. Rheumatoid Arthritis: Leading Biologics Dominate the Market
5.3.1. Rheumatoid Arthritis Market Forecast 2016-2026
5.3.2. All Major Injectable Therapies Are Marketed in Proprietary Devices
5.3.3. Novel Injection Systems for RA: Meeting the Needs of Patients
5.3.4. The Receding Threat from Oral Therapies to 2026
5.4. Growth Hormones: Outlook to 2026
5.4.1. Growth Hormones Market Forecast 2016-2026
5.4.2. Biosimilar Growth Hormones and Pen Injectors
5.4.3. Uptake of Needle-Free Injectors for Growth Hormones
5.5. The Vaccine Market Outlook 2016-2026
5.5.1. Vaccine Market Forecast 2016-2026
5.5.2. Single-Use Devices for Vaccine Delivery
5.5.2.1. BD Uniject: A Private-Public Collaboration
5.5.3. Needle-Free Injectors for Vaccines
5.5.4. Other Trends in Vaccine Delivery
5.6. PCSK9 Inhibitors: The Next Advance in Cholesterol-Lowering Drugs
5.6.1. PCSK9 Inhibitors Market Forecast 2016-2026
5.6.2. PCSK9 Inhibitors and Pre-Filled Syringes/Injectors
6. Leading Pre-Filled Device Therapies 2016-2026
6.1. Leading Insulin Therapies Using Pen Injectors 2016-2026
6.1.1. Lantus: The World’s Best-Selling Insulin Analogue
6.1.1.1. SoloSTAR, ClikSTAR and AllSTAR: Three Pen Injectors for Lantus
6.1.1.2. Lantus: Sales Forecast 2016-2026
6.1.2. NovoLog: The Leading Fast-Acting Insulin
6.1.2.1. NovoLog FlexPen: To Be Retired
6.1.2.2. Novo’s New FlexTouch Pen Launched
6.1.2.3. NovoLog: Sales Forecast 2016-2026
6.1.3. Humalog
6.1.3.1. Humalog: HumaPen and KwikPen
6.1.3.2. Humalog: Sales Forecast 2016-2026
6.2. Top Biologics for Rheumatoid Arthritis: Device Outlook to 2026
6.2.1. Humira: The Biggest-Selling Drug in 2015
6.2.1.1. The Humira Pen Is an Innovative Delivery Device
6.2.1.2. Humira: Sales Forecast 2016-2026
6.2.2. Enbrel: The Leading Competitor to Humira
6.2.2.1. Pre-Filled Injection Devices Available for Enbrel in 2015
6.2.2.2. Enbrel: Sales Forecast 2016-2026
6.3. Growth Hormones: Two Products Dominated the Market in 2015
6.3.1. Norditropin: the Leading Growth Hormone
6.3.1.1. Norditropin: Sales Forecast 2016-2026
6.3.2. Genotropin: Sales Forecast 2016-2026
6.4. Outlook for Leading PCSK9 Products 2016-2026
6.4.1. Praluent (alirocumab, Sanofi/Regeneron)
6.4.1.1. Praluent: Sales Forecast 2016-2026
6.4.1.2. Amgen Suit Against Sanofi/Regeneron’s Praluent
6.4.2. Repatha (evolocumab, Amgen)
6.4.2.1. Repatha: Sales Forecast 2016-2026
7. Leading Pre-Filled Syringe and Related Technology Manufacturers, 2016
7.1. Leading Pre-Filled Syringe Manufacturers in 2015
7.1.1. Becton, Dickinson & Company: The Market Leader
7.1.1.1. Becton, Dickinson & Company: Pre-Filled Syringes Product Portfolio
7.1.1.2. BD Historical Revenue and Market Prospects
7.1.1.3. Recent Acquisitions by BD
7.1.1.4. BD Acquisition of CareFusion
7.1.1.5. BD AutoShield Duo Pen Needle Launched in 2014
7.1.2. Gerresheimer
7.1.2.1. Gerresheimer: Pre-Filled Syringes Product Portfolio
7.1.2.2. Gerresheimer Historical Revenue 2014-2015 and Market Outlook
7.1.2.3. Gerresheimer: Products in Development
7.1.2.4. Patent Application for Gerresheimer’s Gx G-Fix Adapter
7.1.2.5. Gerresheimer Commissioned to Manufacture Simponi Autoinjectors
7.1.2.6. Gerresheimer Opens First Development Center in China
7.1.3. Schott
7.1.3.1. Schott: Pre-Filled Syringes Product Portfolio
7.1.3.2. Schott Historical Revenue and Market Prospects
7.1.3.3. Schott: Expansion in India
7.2. Other Notable Pre-Filled Syringe Manufacturers
7.2.1. Baxter: Providing Contract Manufacturing with Pre-Filled Syringes
7.2.2. Nipro: Leading Japanese Contract Manufacturer
7.2.2.1. Nipro’s 2012 Acquisition of MGlas
7.2.3. Stevanato Group/Ompi: Insulin Vials Market Leader
7.2.4. Weigao: Pre-Filled Syringes for China and Beyond
7.2.5. Unilife: Pre-Filled Safety Syringes
7.2.6. Roselabs: Entered the Market in 2012
7.2.7. Vetter Pharma: Offering Lyo-Ject Dual-Chamber Syringes
7.2.8. Other Companies
7.3. Leading Pen Injector and Autoinjector Manufacturers in 2015
7.3.1. SHL Group
7.3.1.1. SHL Group: Pen Injectors and Autoinjectors Product Portfolio
7.3.1.2. SHL Group Market Prospects
7.3.2. Ypsomed
7.3.2.1. Ypsomed: Pen Injectors and Autoinjectors Product Portfolio
7.3.2.2. Ypsomed Historical Revenue and Market Prospects
7.3.2.3. Ypsomed: Recent Developments
7.3.3. Haselmeier
7.3.3.1. Haselmeier: Pen Injectors and Autoinjectors Product Portfolio
7.3.3.2. Haselmeier: Market Prospects
7.3.4. Owen Mumford
7.3.4.1. Owen Mumford: Pen Injectors and Autoinjectors Product Portfolio
7.3.5. Bespak: Entering the Auto-Injectors Market
7.3.6. Other Leading and Emerging Autoinjector Manufacturers
7.4. Leading Pre-Filled Syringe Component Manufacturers in 2016
7.4.1. Datwyler
7.4.1.1. Datwyler Historical Revenue and Market Prospects
8. Qualitative Analysis of the Pre-Filled Syringes Market 2016-2026
8.1. SWOT Analysis of the Pre-Filled Syringes Market
8.2. Strengths
8.2.1. Pre-Filled Syringes and Pen/Autoinjectors are Used In Chronic Conditions
8.2.2. Device Manufacturers Offer a Range Of Products
8.2.3. Customisation and Product Differentiation
8.2.4. Effective Lifecycle Management
8.3. Weaknesses
8.3.1. Patients with Needle Phobia
8.3.2. Chronic Diseases May Make Pre-Filled Syringes Difficult to Use
8.3.3. Risk of Extractables and Leachables
8.3.4. Higher Cost and Greater Cold Chain and Storage Requirements
8.4. Opportunities
8.4.1. Biosimilars Represent a Growing Market
8.4.2. Viscous and Large-Volume Drugs Require Novel Devices
8.4.3. Technological Developments Expanding Product Portfolios
8.4.4. Many Injectable Drugs in the Pipeline
8.4.5. Growth in Emerging Markets
8.5. Threats
8.5.1. Alternative Technologies: Needle-Free and Bolus Injectors
8.5.2. New Oral Therapies for Many Chronic Conditions
8.5.3. Increasing Regulatory Barriers
8.5.4. Cost Pressures on Healthcare Payers
8.6. STEP Analysis of the Pre-Filled Syringes Market
8.6.1. Social Factors: Rising Disease Incidence and Demand for At-Home Care
8.6.2. Technological Developments: Improved Safety and Administration
8.6.3. Economic Pressures: Pre-Filled Syringes Are Cost Efficient
8.6.3.1. High Barriers to Market Entry Exist
8.6.4. Political Issues: Regulatory Developments for Pre-Filled Syringes
8.7. Regulatory and Safety Outlook for Pre-Filled Syringes, 2016-2026
8.7.1. Needlestick Safety and Prevention
8.7.2. International Regulations for Needlestick Prevention
8.7.2.1. The US: The First Country to Introduce Needlestick Legislation
8.7.2.2. The EU: New Rules from 2013 Onwards
8.7.2.3. Needlestick Safety in Japan
8.7.2.4. Legislation for Needlestick Safety in Emerging Markets
8.7.3. Manufacturers Will Continue to Develop New Devices for Needlestick Prevention
8.7.3.1. Ancillary versus Integrated Safety Devices
8.7.4. Extractables and Leachables
8.7.4.1. Companies Will Reduce Sources of Extractables and Leachables
8.7.4.2. Products that Minimise Extractables and Leachables
8.7.4.3. Protein Aggregation: The Challenge of Biological Drugs
8.7.4.4. Regulatory Requirements for Extractables and Leachables
8.8. Biologics and the Pre-Filled Syringes Market, 2016-2026
8.8.1. Manufacturing Pre-Filled Syringes for Biologics: Glass versus Plastic
8.8.2. Biologics Provide New Challenges for Device Manufacturers
8.8.2.1. Lyophilised Drugs and Dual-Chamber Devices
8.8.3. Delivery Opportunities for High Viscosity Drugs
8.8.4. Are Biosimilars an Opportunity for Pre-Filled Syringe Manufacturers?
8.9. The Role of Patients in Pre-Filled Syringe Industry Development and Growth
8.9.1. Chronic Disease Incidence 2016-2026
8.9.2. The Rise in At-Home Care
8.9.3. Improving Patient Adherence
8.9.4. Injection Devices Must be Developed for Patient Convenience: Human Factors Engineering
8.10. Technological Developments in Pre-Filled Syringes to 2026
8.10.1. Product Differentiation Will be Vital in Crowded Treatment Markets
8.10.2. Product Customisation: Adapting Injection Devices
8.10.3. Trends in Manufacturing Materials for Pre-Filled Syringes
8.10.4. Competing Technologies Will Challenge Pre-Filled Syringes
8.10.4.1. Will Needle-Free Devices Become a Significant Competing Technology?
8.10.4.2. Patients Prefer Oral Drug Delivery
8.11. Outsourcing in the Pre-Filled Syringe Industry
8.11.1. Contract Medical Device Manufacturing
8.11.2. Contract Filling of Pre-Filled Syringes
9. Research Interviews
9.1. Interview with Nemera
9.1.1. Drivers and Restraints in the Pre-Filled Syringes Market
9.1.2. State of the Emerging Markets
9.1.3. Greatest Unmet Need in the Market
9.1.4. Therapeutic Areas Set to Benefit
9.1.5. Therapeutic Areas Set to Benefit
9.1.6. Nemera’s Safe’n’Sound Products
9.1.7. Other Nemera Products
10. Conclusions
10.1. Pre-Filled Syringes and Pen/Autoinjectors: Strong Growth Expected
10.2. The World Pre-Filled Syringes Market in 2015
10.2.1. Current Leading Pre-Filled Syringes Segments
10.2.2. Leading Pre-Filled Syringes Companies
10.2.3. Leading National and Regional Markets
10.3. World Pre-Filled Syringes Market Forecast 2016-2026
10.4. The Future of the Pre-Filled Syringes Market?
10.4.1. Glass Syringes Will Continue to Dominate
10.4.2. Innovation for Growth
11. Glossary
Appendix
Visiongain’s Bespoke Research Service
Some Associated Reports
Visiongain Report Sales Order Form
About Visiongain
Report Evaluation Form
List of Tables
Table 2.1 Currency Exchange Rates, 2015
Table 3.1 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Segment, 2015-2026
Table 3.2 Market Shares (%) of Leading Pre-Filled Syringes Market Segments, by Revenue, 2015, 2020 and 2026
Table 3.3 Glass Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 3.4 Selected Proprietary Polymers for Plastic Pre-Filled Syringes, 2015
Table 3.5 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 3.6 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.1 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by National Market, 2015
Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2015-2026
Table 4.2 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2015-2026 (continued)
Table 4.3 Market Shares (%) of Leading National Pre-Filled Syringes Markets, 2015, 2020 and 2026
Table 4.4 World Pre-Filled Syringes Market: Revenues ($m) and Market Shares (%) by Regional Market, 2015
Table 4.5 World Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by Regional Market, 2015-2026
Table 4.6 Market Shares (%) of Leading Regional Pre-Filled Syringes Markets, 2015, 2020 and 2026
Table 4.7 US Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.8 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.9 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%) by National Market, 2015-2026
Table 4.10 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.11 Indian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.12 Russian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 4.13 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.1 Pen Manufacturing Agreements for Leading Insulin Brand Manufacturers, 2015
Table 5.2 Selected Biosimilar Insulin Pen Injectors, 2016
Table 5.3 Insulin Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.4 Rheumatoid Arthritis Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.5 Growth Hormone Therapies in Pen Injectors, 2016
Table 5.6 Growth Hormones Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.7 Selected Biosimilar Growth Hormones in Emerging Markets, 2016
Table 5.8 Vaccines Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 5.9 PCSK9 Inhibitors Market Forecast: Revenues ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.1 Leading Pre-Filled Insulin Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
Table 6.2 Sanofi: Lantus Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.3 Novo Nordisk: NovoLog Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.4 Eli Lilly: Humalog Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.5 Leading Pre-Filled Rheumatoid Arthritis Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
Table 6.6 AbbVie/Eisai: Humira Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.7 Amgen/Pfizer: Enbrel Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.8 Leading Pre-Filled Growth Hormone Therapies: Revenues ($m), AGR (%) and CAGR (%), 2010-2015
Table 6.9 Novo Nordisk: Norditropin Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.10 Pfizer: Genotropin Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.11 Sanofi: Praluent Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 6.12 Amgen: Repatha Revenue ($m), AGR (%) and CAGR (%), 2015-2026
Table 7.1 BD: Overview, 2016
Table 7.2 BD: Pre-Filled Injection Systems, 2016
Table 7.3 BD: Pharmaceutical Systems Revenue ($m), AGR (%), CAGR (%), 2010-2015
Table 7.4 Gerresheimer: Overview, 2016
Table 7.5 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m) for 2014 and 2015, plus AGR (%)
Table 7.6 Schott: Overview, 2016
Table 7.7 Schott: Net Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.8 Unilife: Pre-Filled Syringe Product Portfolio, 2016
Table 7.9 Unilife: Net Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.10 SHL Group: Overview, 2016
Table 7.11 SHL Group: Pen Injector and Autoinjector Portfolio, 2016
Table 7.12 Ypsomed: Overview, 2016
Table 7.13 Ypsomed: Pen Injector and Autoinjector Portfolio, 2016
Table 7.14 Ypsomed: Delivery Devices Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 7.15 Haselmeier: Overview, 2016
Table 7.16 Haselmeier: Pen Injector and Autoinjector Portfolio, 2016
Table 7.17 Owen Mumford: Overview, 2016
Table 7.18 Owen Mumford: Pen Injector and Autoinjector Portfolio, 2016
Table 7.19 Datwyler: Overview, 2016
Table 7.20 Datwyler: Pharma Packaging Revenue ($m), AGR (%) and CAGR (%), 2010-2015
Table 8.1 Benefits and Weaknesses to Pre-Filled Syringes as an Injectable Delivery Device, 2016
Table 8.2 Pre-Filled Syringes Market: STEP Analysis, 2016-2026
Table 8.3 Selected Safety Products for Pre-Filled Syringes, 2016
Table 8.4 Selected Pre-Filled Injection Devices for Lyophilised Drugs, 2016
Table 8.5 Pre-Filled Syringe Manufacturers: Alternative Injectable Technologies, 2016
Table 8.6 Selected Insulin Pumps Available, 2016
Table 8.7 Oral Drug Competitors for Leading Pre-Filled Syringe Therapeutic Sectors, 2016-2026
Table 8.8 Selected Leading CMOs: Pre-Filled Syringe Filling Capabilities, 2016
List of Figures
Figure 1.1 Global Pre-Filled Syringes Market Segmentation Overview, 2016
Figure 2.1 Diagram of Syringe Parts, 2015
Figure 2.2 Timeline of Pre-Filled Syringe Development, 1950-2015
Figure 2.3 Major Trends for Pre-Filled Syringe Market Growth, 2016
Figure 3.1 World Pre-Filled Syringes Market: Market Shares (%) by Segment, 2015
Figure 3.2 World Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.3 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2015
Figure 3.4 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2020
Figure 3.5 World Pre-Filled Syringes Market by Revenue: Market Shares (%) by Segment, 2026
Figure 3.6 World Pre-Filled Syringes Market: Drivers and Restraints, 2016-2026
Figure 3.7 Glass Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.8 Glass Pre-Filled Syringes Market: Drivers and Restraints, 2016-2026
Figure 3.9 Plastic Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.10 Plastic Pre-Filled Syringes Market: Drivers and Restraints, 2016-2026
Figure 3.11 Pen Injectors and Autoinjectors Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 3.12 Pen Injectors and Autoinjectors Market: Drivers and Restraints, 2016-2026
Figure 4.1 World Pre-Filled Syringes Market: Revenues ($m) by National Market, 2015
Figure 4.2 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2015
Figure 4.3 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2020
Figure 4.4 World Pre-Filled Syringes Market: Market Shares (%) by National Market, 2026
Figure 4.5 World Pre-Filled Syringes Market: Revenues ($m) by Regional Market, 2015
Figure 4.6 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2015
Figure 4.7 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2020
Figure 4.8 World Pre-Filled Syringes Market: Market Shares (%) by Regional Market, 2026
Figure 4.9 US Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.10 Japanese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.11 EU5 Pre-Filled Syringes Market Forecast: Revenues ($m) by National Market, 2015-2026
Figure 4.12 Chinese Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.13 Indian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.14 Russian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 4.15 Brazilian Pre-Filled Syringes Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.1 Insulin Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.2 Rheumatoid Arthritis Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.3 Growth Hormones Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.4 Vaccines Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 5.5 PCSK9 Inhibitors Market Forecast: Revenues ($m) and AGR (%), 2015-2026
Figure 6.1 Sanofi: Lantus Revenue ($m) and AGR (%), 2015-2026
Figure 6.2 Novo Nordisk: NovoLog Revenue ($m) and AGR (%), 2015-2026
Figure 6.3 Eli Lilly: Humalog Revenue ($m) and AGR (%), 2015-2026
Figure 6.4 AbbVie/Eisai: Humira Revenue ($m) and AGR (%), 2015-2026
Figure 6.5 Amgen/Pfizer: Enbrel Revenue ($m) and AGR (%), 2015-2026
Figure 6.6 Novo Nordisk: Norditropin Revenue ($m) and AGR (%), 2015-2026
Figure 6.7 Pfizer: Genotropin Revenue ($m) and AGR (%), 2015-2026
Figure 6.8 Sanofi/Regeneron: Praluent Revenue ($m) and AGR (%), 2015-2026
Figure 6.9 Amgen: Repatha Revenue ($m) and AGR (%), 2015-2026
Figure 7.1 BD: Pharmaceutical Systems Revenue ($m), AGR (%), 2010-2015
Figure 7.2 Gerresheimer: Plastics & Devices and Primary Packaging Glass Segment Revenue ($m), 2014 and 2015
Figure 7.3 Schott: Net Revenue ($m) and AGR (%), 2010-2015
Figure 7.4 Unilife: Net Revenue ($m) and AGR (%), 2010-2015
Figure 7.5 Ypsomed: Delivery Devices Revenue ($m) and AGR (%), 2010-2015
Figure 7.6 Datwyler: Pharma Packaging Revenue ($m) and AGR (%), 2010-2015
Figure 8.1 Pre-Filled Syringes Market: Strengths and Weaknesses, 2016-2026
Figure 8.2 Pre-Filled Syringes Market: Opportunities and Threats, 2016-2026
Figure 10.1 World Pre-Filled Syringes Market Forecast: Revenues ($m) by Segment, 2015-2026
Abbvie
Ache
Amega Biotech
Amgen
Antares Pharma
Aptar Stelmi
AstraZeneca
Baxter International
Becton, Dickinson and Company
Bespak
Biocon
Bioject Medical Technologies
Biomarin
Biosidus
Boehringer Ingelheim
Bristol-Myers Squibb
Cambridge Consultants
CareFusion Corporation
Celgene
Centocor
Daikyo Seiko
Datwyler
Dong-A
Dr. Reddy’s
Eisai Pharmaceutical
Eli Lilly
Ferring
Gan & Lee
GeneScience Pharmaceuticals
Gerresheimer
GlaxoSmithKline
Haselmeier
Helvoet Pharmaceutical
Hospira
Incepta Pharmaceuticals
Janssen Biotech
Johnson and Johnson
LG Life Sciences/Biopartners
Mannkind
Merck & Co
Merck Serono
Mitsubishi Tanabe
Nektar Therapeutics
Nipro
Novartis
Novo Nordisk
OPKO Health
Oval Medical
Owen Mumford
PA Consulting Group
Palatin Technologies
Pfizer
PharmaJet
Pharmstandard
Polfa Tarchomin
Regeneron
Rhone Poulenc-Rorer
Roehr Products
Roselabs Bioscience
Samsung Bioepis
Sandoz
Sanofi
Schott
Schott Kaisha
Schott Xinkang Pharmaceutical Packaging
SciGen
Shanghai Celgen Bio-Pharmaceutical
Shanghai CP Guojin
SHL Group
Square Pharmaceuticals
Stevanato Group (Ompi)
Takeda Pharmaceutical
Terumo
Teva Pharmaceutical
Tonghua Dongbao
UCB
Unlife
Vetter
Vetter Pharma
Weigao
West Pharmaceuticals
Wockhardt
Ypsomed
Zeon
Organisations Mentioned in the Report
Battele Memorial Institute
Carl Zeiss Foundation
Centers for Disease Control (US)
European Society of Cardiology
National Health Service (UK)
Parenteral Drug Association
PATH
UNICEF
US Agency for International Development
US Federal Drug Administration
World Health Organization
Download sample pages
Complete the form below to download your free sample pages for Pre-Filled Syringes Market Forecast 2016-2026Download sample pages
Complete the form below to download your free sample pages for Pre-Filled Syringes Market Forecast 2016-2026Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
If so, please drop an email to Sara Peerun stating your chosen report title to sara.peerun@visiongain.com
What are the dynamic growth sectors? where are the regional business opportunities?
Which technologies will prevail and who are the leading companies succeeding in these sectors and why?
If you want definitive answers to business critical questions, discover Visiongain’s full range of business intelligence reports.
If so, please email Sara Peerun on sara.peerun@visiongain.com or call her today on +44 (0) 20 7549 9987
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia

Click here to ‘Like’ our Facebook page https://www.facebook.com/V.G.Pharma/
Latest Pharma news
Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030
The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.
12 April 2021
Visiongain Publishes Cell-Based Assays Market Report to 2030
Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.
09 April 2021
Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031
The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.
06 April 2021
Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031
Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.
01 April 2021